Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Jun;85(6):635-8.
doi: 10.1136/heart.85.6.635.

The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis

Affiliations

The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis

J R Ortlepp et al. Heart. 2001 Jun.

Abstract

Objective: To test the hypothesis that vitamin D receptor polymorphism is associated with calcific aortic valve stenosis.

Design: The distribution of one polymorphism of the vitamin D receptor (BsmI B/b) was examined in 100 consecutive patients with calcific valvar aortic stenosis and compared with a control group of 100 patients (paired match for age, sex, and the presence of coronary artery disease from a total of 630 patients without calcified aortic valves). Polymerase chain reaction and restriction fragment length polymorphism were used to determine genotypes.

Results: There was a significant difference in vitamin D receptor allele and genotype frequencies between the two groups. The allele B had a higher prevalence in patients with calcific aortic stenosis (B = 0.56, b = 0.44) than in the control cohort (B = 0.40, b = 0.60) (p = 0.001).

Conclusions: There is a significant association of vitamin D receptor polymorphism with calcific aortic valve stenosis. The B allele of the vitamin D receptor is more common in patients with calcific aortic valve stenosis. It now needs to be evaluated whether other genes that control calcium homeostasis are involved in the pathogenesis of this disorder.

PubMed Disclaimer

Comment in

References

    1. Mayo Clin Proc. 1987 Feb;62(2):119-23 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6665-9 - PubMed
    1. Nature. 1994 Jan 20;367(6460):284-7 - PubMed
    1. Circulation. 1994 Aug;90(2):844-53 - PubMed
    1. Lancet. 1995 Feb 18;345(8947):423-4 - PubMed

Publication types